Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Deepcell, a US-based developer of an artificial intelligence-powered platform for single cell classification and isolation for basic and translational research, closed a $73m series B round yesterday led by Koch Disruptive Technologies, an investment subsidiary of chemicals and energy conglomerate Koch Industries. The round also included Bridger Healthcare, Horizons Ventures, Casdin Capital, Andreessen Horowitz, Bow…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
